Sino Biopharm files HKEX next-day return disclosing share buyback cancellation at HKD 4.46 each

• Sino Biopharmaceutical filed a next-day disclosure return showing 22,065,000 shares repurchased and cancelled.
• Buyback price averaged HKD 4.46 per share; issued shares fell 0.12% to 18,682,952,230 as of July 13.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sino Biopharmaceutical Limited published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260713-12242218), on July 13, 2026, and is solely responsible for the information contained therein.